Skip to main content
Premium Trial:

Request an Annual Quote

Bico to Acquire Lab Workflow Software Maker Biosero for $165M

NEW YORK — Bico said on Thursday that it will acquire Biosero, a San Diego-based provider of lab workflow software, for $165 million in cash and stock.

Bico said that it has entered agreements with Biosero shareholders to acquire all of the company's outstanding shares for roughly $103.9 in cash, $34.7 million in consideration shares, and $26.4 in a combination of cash and stock paid out over the next three years.

According to Bico, the acquisition will allow it to offer its customers fully automated and connected lab workflow solutions, as well as boost its software capabilities. The Boston-based firm said that it will also invest $20 million in Biosero over the three years to expand its commercial presence in the US, Europe, and Asia, and to accelerate its R&D efforts.

Biosero has approximately 75 employees and is expected to generate $26 million in revenues this year, Bico said. Applications for its software include genomics, genomic surveillance, cell biology, proteomics, compound management, and clinical diagnostics, according to the company's website.

"With Biosero, we take a significant and strategized step in expanding our portfolio with combinatorial smart software systems to enable automated workflows," Bico cofounder and CEO Erik Gatenholm said in a statement. "The Biosero software platform will serve as a glue to our impressive portfolio of hardware instruments and solutions, tying together the great hardware technologies we have acquired over the years."

In October, Bico — formerly Cellink — acquired sample preparation and liquid handling company QInstruments for about $71 million. Last year, it bought German precision dispensing firm Scienion for roughly $94.8 million.

The Scan

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Targets Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.